FSA & HSA eligible
Weight Loss Oral Medication Kits
Weight loss treatment plans to help reduce appetite and curb cravings with oral medications.
Important safety information:
, , , ,Meet oral medication kits
As part of your weight loss plan, you can access a custom oral medication kit if a provider determines it’s right for you and your weight loss goals.
How to take
If prescribed, a licensed provider will provide treatment instructions with your weight loss plan. These medications are taken orally once or twice daily depending on your unique weight loss goals.
Potential side effects
It’s common to experience some side effects like nausea as you adjust to the medication. A fast-acting anti-nausea medication is included with treatment at no extra cost, if eligible.
Metformin's potential side effects include nausea, diarrhea, and upset stomach. Taking medication with meals can help reduce these side effects.
Bupropion’s potential side effects include trouble sleeping and feeling anxious.
Topiramate's potential side effects include tingling of the arms and legs (paresthesia), changing how foods taste, especially with carbonated beverages, sleepiness/drowsiness, difficulty with memory, effects on thinking and alertness, and kidney stones.
Naltrexone's potential side effects include nausea and vomiting.
Personalized through Hims
We’re here for you every step of the way as you adjust to your medication
Your custom kit, dosage, and how fast you increase is personalized to you and your provider can help make adjustments as needed, anytime
Unlimited provider messaging at no extra cost
Free easy-to-follow guides on how to get started made by weight loss experts in the Hims app
Select your plan
subscribe to save
More than
motivation
Underlying factors, like genetics and hormones, can cause cravings and hunger, making weight loss difficult.
Made to
fit you
Based on your needs, a provider may recommend a mix of medications to help address these factors.
Winning
team
These medication combinations can make it easier to develop healthy habits for long-term weight loss.
Learn more about oral medication kits
What to expect with oral medications.
How to take
Daily; orally with water.
Common side effects
- If prescribed, your provider will start your treatment at a lower dose to help minimize common early possible side effects and help your body adjust.
- While your body adjusts to the medication, you may experience some mild side effects. This is common and should subside over the first month. Side effects are a common part of the weight loss treatment journey. If you experience more serious side effects, reach out to your medical provider.
What are my weight loss treatment options through Hims?
Hims offers customized weight loss plans designed to meet your unique weight loss goals. Your provider may recommend a combination of medications, such as GLP-1 injections and oral medication kits.
We also offer evidence-based content, tips and tricks, and convenient recipes that will help you achieve the results you’re looking for.
Do you prescribe GLP-1s?
Hims offers access to compounded semaglutide (compounded GLP-1) as well as name brand options like Ozempic® and Wegovy® which are all injected weekly, if prescribed by a licensed provider.
What medications do you offer?
There are plenty of brand name and generic prescription drugs that the U.S. Food and Drug Administration has approved for people struggling with high BMI (body mass index), obesity, or other weight-related health conditions. Medications such as Ozempic® (semaglutide), Wegovy® (semaglutide), Rybelsus® (semaglutide), Mounjaro® (tirzepatide), Zepbound® (tirzepatide), Saxenda® (liraglutide), IMCIVREE® (setmelanotide), Qsymia® (phentermine-topiramate), Adipex-P® (phentermine), Lomaira® (phentermine), Alli® (orlistat), Xenical® (orlistat), Contrave® (naltrexone-bupropion), as well as other medications like antidepressants prescribed off-label. Many have also had clinical trials.
Through Hims you can get access to compounded semaglutide (the same active ingredient as Ozempic® and Wegovy®).
Hims offers access to personalized prescription medication kits that can include metformin, bupropion, topiramate, vitamin B12, and naltrexone. Taken as a once-daily pill, these medications work in different ways to support your weight loss goals.
Your provider will help you find the right medication based on your custom weight loss profile.
How much does weight loss treatment cost?
Through Hims you can get GLP-1 weight loss drugs for as little as $165 a month (when you sign up for a 12-month plan which you’ll pay for upfront in full). The oral medication kits start at just $69 a month with a 10-month plan. Total pricing varies at checkout.
Medications like GLP-1s actually don’t have to cost thousands of dollars every month without the brand name markup. At Hims, we are leveraging our size and scale to ensure access to high-quality supplies of compounded GLP-1s. This keeps prices low for our customers and ensures that providers through Hims can prescribe what is truly best for you.
How do I get started with my weight loss treatment?
You’ll begin by answering questions about your medical history and weight loss goals to create a custom weight loss profile. A licensed healthcare professional will review your information—all 100% online.
If treatment is right for you, you’ll receive a message from a provider with information about your personalized plan.
For people who haven’t had success losing body weight with lifestyle changes, counting calories, or over-the-counter options like supplements, weight loss medication can be a helpful addition to a comprehensive weight loss plan.
Be sure to share any underlying health conditions, health problems, or medical conditions with your healthcare provider as you start your weight management journey such as heart disease, type 2 diabetes, high cholesterol, high blood pressure, glaucoma, pancreatitis, thyroid conditions, blood sugar issues, constipation, heart disease, recent hospitalization, or any other adverse events in your health, or if you are pregnant or breastfeeding. Only take medical advice from a licensed medical provider.
Are video visits with a doctor required?
No video visit is required; a provider will review your information 100% online. If prescribed, you’ll get unlimited online access to message your provider as needed for follow-ups, adjustments, and answers to your questions.
Is insurance required?
No, Hims does not require insurance. We have a straight-forward approach to pricing and billing, as well as affordable generic options to make taking care of yourself as simple as possible.
How can I reimburse with FSA/HSA?
You can download a receipt of your eligible expenses and submit online for reimbursement through your FSA or HSA. Head to the "orders" tab to find your receipt.
From there, you can download your receipt and follow your FSA/HSA provider's reimbursement instructions.
What is compounded semaglutide?
Working with a licensed compounding pharmacy, Hims is able to provide medications to meet our patients’ unique needs. Hims offers compounded semaglutide, a GLP-1 injection with the same active ingredient as Wegovy® and Ozempic®.
This differs from brand-name weight loss injections, which typically come in a preloaded injection pen. But don’t worry, Hims will show you exactly how to take your injection. And you’ll have access to unlimited messaging.
How much weight can I lose with weight loss medications?
As a science-backed weight loss program that’s been developed by experts, your unique treatment plan is designed to support healthy, sustainable results.
Because everyone’s weight loss journey is different, the timeline for results may vary from person to person. In general, it’s important to incorporate healthy lifestyle and wellness changes such as:
- Taking your medication as directed
- Supporting your progress with healthy nutrition
- Incorporating consistent, moderate physical activity into your routine
How is Hims dealing with GLP-1 shortages?
Through Hims, you can find GLP-1s like Ozempic® and Wegovy®—but knowing that the availability of those medications can change, Hims is working closely with trusted partners to support our customers in accessing the weight loss treatment that is right for them using pharmacy compounding.
While name-brand FDA-approved drugs like Ozempic® and Wegovy® are currently in short supply, Hims also provides compounded versions of GLP-1s formulated with the same active ingredient. The formulations of these compounded semaglutide products are held to high quality standards and developed in FDA-regulated facilities. This means you can start your weight loss journey with confidence even while other drugs may be on the FDA drug shortage list.
Compounded semaglutide, including Hims & Hers’ product, is not approved or evaluated for safety, efficacy, or quality by FDA. Wegovy® (semaglutide) and Ozempic® (semaglutide) are not compounded. Wegovy® (semaglutide) is FDA-approved for weight loss. Ozempic® (semaglutide) is FDA-approved for type 2 diabetes treatment but may be prescribed off-label for weight loss at a healthcare provider’s discretion.
Who qualifies for compounded GLP-1s at Hims?
A state-licensed provider reviews the health history, weight loss goals, and unique patient needs of every individual patient to see if they qualify before prescribing any kind of treatment.
Are GLP-1s available in all states?
Unfortunately, GLP-1s are not yet available in all 50 states; however, Hims is working to expand our offering as soon as possible.
How long do I need to stay on medication?
Medication is a long-term use weight loss treatment not meant for short-term use. When you stop taking it, the triggers that previously drove unhealthy eating behaviors may return. Always speak with a licensed medical provider before stopping treatment.
When will I see results?
Remember, results aren’t instant. Because everyone’s weight loss journey is different, the timeline for results may vary from person to person.
What is a certificate of analysis?
It’s a document that verifies a compounded GLP-1 prescription’s consistency, consistency, and potency.
How are compounded GLP-1s sourced?
The ingredients are sourced from FDA-regulated suppliers and the treatments are compounded in FDA-regulated facilities.
Featured reviews
80% of compounded GLP-1 customers feel healthier
since starting weight loss treatment through Hims & Hers.*
Important Safety Information
- >27 kg/m2 or greater (overweight or obesity)
- Co-administration with other COMPOUNDED SEMAGLUTIDE-containing products or any GLP-1 receptor agonist is not recommended.
- The safety and efficacy of coadministration with other products for weight management have not been established.
- COMPOUNDED SEMAGLUTIDE has not been studied in patients with a history of pancreatitis.
- In rodents, SEMAGLUTIDE causes thyroid C-cell tumors in clinically relevant exposures. It is unknown whether SEMAGLUTIDE causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans as the human relevance of SEMAGLUTIDE-induced rodent thyroid C-cell tumors has not been determined
- SEMAGLUTIDE is contraindicated in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Counsel patients regarding the potential risk of MTC and symptoms of thyroid tumors.
- Have a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN2).
- Have been diagnosed with Diabetes (Type 1 or 2)
- Have been diagnosed with pancreatitis or history of pancreatitis
- Have a diagnosis or history of gastroparesis - severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis) or problems with digesting food
- Have a known allergy to semaglutide/any other GLP-1 drug or any of the inactive ingredients in COMPOUNDED SEMAGLUTIDE. Inactive ingredients include: di-sodium hydrogen phosphate dihydrate, sodium chloride, benzyl alcohol, hydrochloric acid, sodium hydroxide pellets and water.
- Have a history of suicidal attempts or active suicidal ideation
- Acute Pancreatitis: Has occurred in clinical trials. Discontinue promptly if pancreatitis is suspected. Do not restart if pancreatitis is confirmed.
- Acute Gallbladder Disease: Has occurred in clinical trials. If cholelithiasis is suspected, gallbladder studies and clinical follow-up are indicated.
- Gastroparesis: Uncommon, but more serious, gastrointestinal adverse effect may also occur more frequently with GLP-1 receptor agonists than with other weight loss agents.
- Hypoglycemia: Concomitant use with an insulin secretagogue or insulin may increase the risk of hypoglycemia, including severe hypoglycemia. Reducing the dose of insulin secretagogue or insulin may be necessary. Inform all patients of the risk of hypoglycemia and educate them on the signs and symptoms of hypoglycemia.
- Acute Kidney Injury: Has occurred. Monitor renal function when initiating or escalating doses of COMPOUNDED SEMAGLUTIDE in patients reporting severe adverse gastrointestinal reactions or in those with renal impairment reporting severe adverse gastrointestinal reactions.
- Hypersensitivity Reactions: Anaphylactic reactions and angioedema have been reported postmarketing. Discontinue COMPOUNDED SEMAGLUTIDE if suspected and promptly seek medical advice.
- Females and males of reproductive potential: Discontinue COMPOUNDED SEMAGLUTIDE at least 2 months before a planned pregnancy because of the long half-life of COMPOUNDED SEMAGLUTIDE.
- Pregnancy: May cause fetal harm. When pregnancy is recognized, discontinue COMPOUNDED SEMAGLUTIDE immediately
- Diabetic Retinopathy Complications in Patients with Type 2 Diabetes: Has been reported in trials with COMPOUNDED SEMAGLUTIDE. Patients with a history of diabetic retinopathy should be monitored. Diabetic retinopathy damages blood vessels in the retina and can scar your retina. As the scars get bigger, they can pull on your retina and detach it from the back of your eye, a serious condition called retinal detachment.
- Heart Rate Increase: Monitor heart rate at regular intervals.
- Suicidal Behavior and Ideation: Monitor for depression or suicidal thoughts. Discontinue COMPOUNDED SEMAGLUTIDE if symptoms develop.
- A recent study suggested there may be a connection between semaglutide use and increased risk for a blinding eye disease called non-arteritic anterior ischemic optic neuropathy (NAION). There isn't enough data yet to suggest patients should be concerned or should stop taking their medications. People who have diabetes are already at risk for NAION, whether they use semaglutide or not. It is premature to conclude that the association is a causal association. More research is necessary to test the hypothesis. Until then, patients should be aware of this information and make a careful, informed choice based on their individual risk profile.
- Pregnancy: May cause fetal harm. When pregnancy is recognized, discontinue COMPOUNDED SEMAGLUTIDE.
- Females and Males of Reproductive Potential: Discontinue COMPOUNDED SEMAGLUTIDE at least 2 months before a planned pregnancy because of the long half-life of COMPOUNDED SEMAGLUTIDE.